Novo Nordisk India Reduces Prices Amid Rising Competition

Novo Nordisk India has announced a reduction in prices for its popular weight-loss and diabetes medications. Bloomberg posted on X that this move comes as the Danish pharmaceutical company faces increasing competition from cheaper generic alternatives in India, which ranks as the third most overweight country globally. The price cuts aim to maintain Novo Nordisk's market share in the face of growing challenges from local manufacturers offering more affordable options. This strategic adjustment reflects the company's efforts to adapt to the competitive landscape in the Indian pharmaceutical market.